NCT02778659

Hypnotic Intake and Motor and Cognitive Performances at High Altitude

The Effect of Acute Hypnotic Intake Before a Night at High Altitude on Cognitive and Motor Performances

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Centre d'Expertise sur l'Altitude EXALT · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This study aims to determine the effect of acute hypnotic intake (Zolpidem) on sleep, cognitive and motor performances and on acute mountain sickness symptoms at high altitude. Healthy subjects will be evaluated on 4 occasions (twice at sea level and twice at high altitude), after hypnotic or placebo intake. Following an early wake-up (01:00), symptoms, cognitive and motor performances will be assessed to determine potential residual effects of Zolpidem within such conditions.

Conditions

• Physiology

Interventions

Type	Name	Description
DRUG	Zolpidem	The hypnotic will be administrated orally at 22:00 in the evening before a sleep recording and an early wake-up at 01:00 for cognitive and motor assessment.
DRUG	Placebo	The placebo will be administrated orally at 22:00 in the evening before a sleep recording and an early wake-up at 01:00 for cognitive and motor assessment.

Timeline

• Start date: 2016-05-01
• Primary completion: 2017-10-01
• Completion: 2017-10-01
• First posted: 2016-05-20
• Last updated: 2018-01-05

Locations

1 site across 1 country: France